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Abstract
Background: Tuberculosis (TB) is a global health problem complicated by drug resistance and human immunodeficiency
virus that has dramatically increased active TB. Several medicinal plants are used traditionally to treat TB in Ethiopia and
investigating these plants is required as plants are an alternative source for development of new anti-TB drugs. The
purpose of this study was to investigate antimycobacterial activity of crude extract of Carissa edulis, Otostegia integrifolia,
Persea americana, Pterolobium stellatum and Vernonia amygdalina as well as fractions of the most active crude extract.
Methods: The effect of various doses of the crude extracts as well as solvent fractions on M. tuberculosis H37Rv and/or
MDR-TB clinical isolate was determined using broth microdilution and microtiter resazurin assay methods. Minimum
inhibitory concentration was determined by CFU count and resazurin color change observation.
Results: Chloroform and 80% methanol extracts of P. stellatum and O. integrifolia as well as 80% methanol and acetone
extracts of P. americana had significant antimycobacterial activity (p < 0.001) against M. tuberculosis H37Rv. Chloroform
extract of V. amygdalina and C. edulis didn’t, however, show any significant activity compared to negative controls. P.
stellatum chloroform extract was the most active on M. tuberculosis H37Rv (MIC 0.039 mg/ml) and AOZ8W-4 (MDR-TB
clinical isolate) (MIC = 0.078 mg/ml). Ethyl acetate fraction of P. stellatum chloroform extract was the most active fraction.
Conclusion: P. stellatum, O. integrifolia and P. americana were found to be endowed with antimycobacterial activity.
However, P. stellatum appears to be the most promising plant based on criteria set by different studies. Ethyl acetate
fraction of P. stellatum was found to be the most active and future studies should involve this fraction.
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Background
Mycobacterium tuberculosis, an obligate aerobe belonging
to the M. tuberculosis complex (also include M. bovis,
M. africanum and M. microti), is the most important
cause of TB in humans. In addition to M. tuberculosis
complex, Mycobacterium avium complex (include M.
avium, M. intracellularae, and M. kansasii) can also
cause closely related mycobacterium diseases in AIDS
patients and is difficult to distinguish as a group
clinically [1].
In 1993, during the world TB day, WHO declared TB as
a ‘global emergency,’ which requires emergency action and
launched several programs to combat the disease, includ-
ing the search for newer remedies and/or anti-TB agents
to complement currently used agents [2]. In the year
2014, TB killed 1.5 million people (1.1 million HIV-
negative and 0.4 million HIV-positive) and 9.6 million
new cases of active tuberculosis globally caused by TB [3].
Mycobacteria are slow growing organisms that require
administration of a combination of drugs for extended
periods to achieve effective therapy and to prevent the
emergence of resistance. The risk of adverse reactions
therefore must be a major consideration in drug selec-
tion. Apart from significant toxicity, lengthy therapy also
creates poor patient compliance. Non-compliance is a
frequent cause of a deadly multidrug resistant TB
(MDR-TB) and extensively drug resistant TB (XDR-TB).
Drug toxicity coupled with the problem of mycobacterial
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persistence highlights the need to develop novel TB
drugs that are active against drug resistant bacteria and
kill persistent bacteria as well as shorten the length of
TB treatment [4].
Natural products, either as pure compounds or as stan-
dardized plant extracts, provide unlimited opportunities
for new drug leads because of the unmatched availability
of chemical diversity [5]. Scientific interest in medicinal
plant has grown in recent times because natural products
are evolutionary shaped drugs or drug‐like molecules.
Nature’s biosynthetic machinery produces innumerate
natural products with distinct biological properties that
make them valuable as inhibitors or promoters of
biological action [4, 6]. Moreover, higher plant extracts
have been considered as promising sources of novel anti-
TB leads [7]. This has prompted us to investigate selected
Ethiopian medicinal plants, including Carissa edulis Vahl
(Apocynaceae), Otostegia integrifolia Benth (Lamiaceae
(Labiatae)), Persea Americana Mill (Lauraceae), Pterolo-
bium stellatum (Forsk.) Brenan. (Fabaceae), and Vernonia
amygdalina Del. (Asteraceae) for possible anti-TB activity.
The plants have been traditionally used to treat respiratory
or lung-related diseases, including TB for a very long time
[8–11]. The present study attempted to screen the
antmycobacterial activity of different solvent extract of
these five Ethiopian medicinal plants, and Pterolobium




The roots of O. integrifolia, P. stellatum, and C. edulis
were collected from an area near Angereb River, Gondar
town, North West Ethiopia, about 730 km away from
the capital, Addis Ababa. The root of V. amygdalina and
the leaves of P. americana were collected from Bure
town, North West Ethiopia, about 400 km far from
Addis Ababa. The plants were authenticated by a
taxonomist (Mr. Melaku Wondafrash) and a voucher
specimen of each plant material was deposited at the
National Herbarium, College of Natural and Computa-
tional Sciences, Addis Ababa University for future refer-
ence with voucher numbers Wk001, WK002, WK003,
WK004 and WK005 for O. integrifolia, P. stellatum, C.
edulis, V. amygdalina and P. americana, respectively.
The plants were cleaned from dirt and soil and dried
under shade for two weeks. The plants were spread out
and regularly turned over to avoid fermenting and
rotting. The dried root parts of plants were grinded
using 0.75 mm sieve size hammer type mill, while the
dried leaves were pulverized using a wooden mortar and
pestle. The powdered material was weighed using an
analytical balance and stored at room temperature.
Experimental animals
Swiss albino nulliparous and non-pregnant female mice
weighing 31–36 g, and age 8–12 weeks were obtained
from the Department of Pharmacology and Clinical
Pharmacy, School of Pharmacy, Addis Ababa University.
All animals were housed in an air-conditioned room and
allowed to acclimatize for one week before commence-
ment of the study. All the experiments were conducted
in accordance with internationally accepted laboratory
animal use, care and guideline [12] and the study was
approved by the School of Pharmacy Ethics Committee
(Protocol number was 042/12/pharmacy). Before and
during the experiment, mice were allowed free access to
standard pellets and water ad libitum.
Bacterial strains and inoculums preparation
Bacterial cells were M. tuberculosis H37Rv (ATCC no
27294, Manassas, VA) and three MDR-TB clinical isolate
strains. The three MDR-TB clinical isolates were
AOA8W-4, AOZ8W-4 and SO38SW-4. M. tuberculosis
and MDR-TB strains were cultured and grown on
Mycobacteria 7H11 medium following procedures
described elsewhere [13]. The inoculum was then pre-
pared by diluting cultures at 1/1000 by adding 25 μl cell
culture to 25 ml medium, 7H9 broth (4.7 g of Middleb-
rook 7H9 broth base [Difco - Becton Diskinson], 2 ml of
glycerol in 900 ml water) enriched with ADC when cooled
to 47 °C [13].
Extraction of plant materials
Crude extract
The air-dried, powdered roots of P. stellatum, O. integri-
folia, C. edulis and V. amygdalina were exhaustively
extracted with chloroform using maceration technique,
while P. americana powdered leaves were extracted with
acetone. Up on using chloroform and acetone solvents,
maceration was carried out using one liter of the
respective solvent for 72 h, with regular shaking. The
mixture was filtered with Whatman No. 42 filter paper
and the filtrate was kept at + 4°c. The marc was macer-
ated again in the same solvent two times and filtered.
The filtrates were combined evaporated under reduced
pressure on a rotary evaporator (Buchi Rota Vapor
R-200) and dried in oven at 40°c (Gallenkamp, England).
In parallel, the air-dried and powdered roots of P.
stellatum, O. integrifolia and powdered leaves of P.
americana were Soxhlet extracted with 80% methanol
(4:1, methanol: water). The obtained extracts were
filtered and evaporated under reduced pressure on a
rotary evaporator and lyophilized. The extracts were
kept refrigerated and away from light. Stock solutions of
all extracts were prepared in DMSO at a concentration
of 50 mg/ml and stored at −20 °C until use.
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Fractionation
Antimycobacterial activity evaluation of the crude
extract revealed P. stellatum chloroform root extract to
have a better activity and further fractionation was
pursued using this plant. The dried extract (8 g) was sus-
pended in distilled water (200 ml) and then successively
partitioned with n-hexane and ethyl acetate in a separ-
atory funnel. The n-hexane and ethyl acetate fractions
were concentrated under reduced pressure using rotary
evaporator (Buchi Rota Vapor R-200) and dried in an
oven under 40 °C, while the water fraction was dried
using freeze drier.
Acute oral toxicity test
As no toxicity data was available for any part of P. stellatum
chloroform extract, oral toxicity study was conducted using
Organization for Economic Cooperation and Development
(OECD) guidelines 423 [14]. Briefly, nine mice were ran-
domly divided into three groups of three mice per cage.
Before administration of single dose of the extract, the mice
were fasted for 3 h and weighed. After administration of a
single dose of extract, mice were fasted for 1 h. The first
group was given solvent (5% DMSO in distilled water),
while the second group were given 2 g/kg (dissolved in 5%
DMSO) of the chloroform root extract of P. stellatum
orally. The mice in the third group were provided with P.
stellatum root extract 5 g/kg dissolved in 5% DMSO after
following the first two groups for 14 days. The mice were
observed continuously for 1 h after administration of the
extract; intermittently for 4 h, over a period of 24 h, and
then frequently for 24 h for 14 days. Gross behavioral
changes such as loss of appetite, hair erection, lacrimation,
tremors, convulsions, salivation, diarrhea, mortality and
other signs of toxicity manifestation were observed.
In vitro antimycobacterial assay
Colony count assay
The antimycobacterial effect of the extracts was evalu-
ated at concentrations ranging from 0.00244 mg/ml to
2.5 mg/ml. The test concentrations of the extracts were
selected based on cytotoxicity test results in previous
studies [4, 10, 15, 16]. Serial two-fold dilution of extracts
was made in microtiter wells. Colony forming units
(CFUs) were counted from triplicate dilutions and dupli-
cate plates were used for each concentration of test
extract and controls. The average CFUs were determined
from three independent experiments. The percentage
inhibition of growth was determined by dividing the
CFUs of the test concentration by the CFUs of the nega-
tive control (solvent).
Each extract reconstituted with DMSO (50 mg/ml)
was further diluted (5 mg/ml) with Middlebrook 7H9
broth supplemented with Middlebrook ADC. Activity
was then measured and MIC was determined for the
extracts as well as positive and negative controls follow-
ing a method described elsewhere [13, 17]. The MIC
was the concentration of extract at which 100% inhib-
ition of mycobacterial growth was observed when com-
pared with the growth control.
Resazurin indicator assay
M. tuberculosis H37Rv and clinical isolates of MDR-TB
were cultured in Middlebrook 7H9 broth at 37 °C for
two weeks in order to reach logarithmic phase growth.
Test inoculums were prepared using a procedure
described by Patricia and colleagues [18]. After incuba-
tion at 37 °C for 7 days, 15 μl of 0.01% resazurin solution
in sterile water was added to the first growth control
wells and incubated for 24 h. Once the first sets of
growth controls turned pink, the dye solution was added
to the second set of growth controls and the test wells,
incubated for 24 h at 37 °C. Blue color in the wells
containing the test compounds would indicate inhibition
of growth, while pink indicates lack of inhibition of
growth of M. tuberculosis [19]. MIC value was expressed
as the lowest concentration of compound that caused
100% inhibition of mycobacterium growth [18]. All
assays were run in triplicate and isoniazid was used as
positive and DMSO as negative control.
Statistical analysis
Data are expressed as mean ± standard error of mean as
appropriate and Statistical analysis of all results was
done using the Statistica 10 and GraphPad Prism 5 soft-
ware. Analysis was done using one-way ANOVA
followed by Duncan post hoc test. Level of statistical
significance was set at α < 0.05.
Results
Information pertaining the preparation of the crude
extracts is depicted in Table 1.
Acute oral toxicity test
Acute oral administration of the chloroform extract of P.
stellatum at different doses showed no overt signs of
distress for the 14-day observation period. Moreover,
there were no observable symptoms of toxicity or deaths
even at a dose of 5 g/kg. This indicates that the oral
LD50 was greater than 5 g/kg. All treatment and control
group mice gained weight and no significant changes in
behavior was noted, suggesting that administration of the
crude extract had negligible level of toxicity on growth of
the animals. In addition, gross behavioral changes such as
loss of appetite, hair erection, lacrimation, tremors, con-
vulsions, salivation, diarrhea, mortality and other signs of
toxicity manifestations were not observed.
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Antimycobacterial activity testing using CFU method
Good growth of M. tuberculosis H37Rv was evident in
the microtiter plate wells containing only liquid
Middlebrook 7H9 medium and in the universal Petri
dishes containing solid Mycobacteria 7H11 medium,
within three to four weeks. DMSO control at 2.5 to
0.0024%, equivalent to solvent concentrations in test
extracts, exhibited no inhibitory effect on mycobacterial
growth as evidenced by higher CFU/ml (Table 2).
Among the different concentrations of isoniazid used,
total inhibition of growth of mycobacteria was observed
at a concentration of 0.125 μg/ml.
Extracts showed differential effects on the proliferation
of Mycobacterium tuberculosis. The chloroform extract of
P. stellatum appeared to be the most active as growth was
totally inhibited at concentrations as low as 0.039 mg/ml.
Concentrations more than 0.3 mg/ml were required to
bring about no growth with the 80% methanol extract of
P. stellatum and O. integrifolia as well as with the chloro-
form extract of O. integrifolia. For the rest of the extracts,
increasing concentrations (>1 mg/ml) were associated
with growth arrest (Table 2).
The chloroform and 80% methanol extracts of P.
stellatum and O. integrifolia as well as 80% methanol
and acetone extracts of P. americana had significant
antimycobacterial activity (α < 0.001) againstM. tuberculosis
H37Rv compared to vehicle treated group. By contrast, V.
amygdalina and C. edulis chloroform extracts did not have
any detectable effect. It is interesting to note that although
there was complete inhibition of growth of M. tuberculosis
H37Rv at concentrations greater than 1.25 mg/ml for V.
amygdalina and C. edulis chloroform extracts, the differ-
ence failed to reach statistical significance (Table 2).
Activity testing of crude extract on clinical isolates using
Resazurin indicator method
As the chloroform extract of P. stellatum demonstrated
the highest activity (MIC = 0.039 mg/ml) against the
standard strain in the CFU method, screening of the
activity of this extract against clinical isolates of MDR-TB
was carried out using resazurin indicator method. The
resazurin assay results are depicted in Table 3. Color read-
ings of the growth control wells were pink, demonstrating
high levels of mycobacterial growth, while wells with broth
alone appeared as blue color, which demonstrated no
growth and lack of contamination. The isoniazid contain-
ing control wells were pink revealing the clinical isolates
were isoniazid resistant. Whilst the extract demonstrated
highest activity against AOZ8W-4 strain (MIC 78 μg/ml),
it had a moderate activity against both AOA8W-4 and
SO38SW-4 strain (MIC 156 μg/ml).
Activity testing of solvent fractions on standard strains
using Resazurin method
As presented in Table 4, n-hexane and aqueous fractions
were evaluated in a concentration series of 1000 to
0.977 μg/ml, while ethyl acetate fraction with 200 to
0.195 μg/ml concentrations. The microtiter wells were
pink below a concentration of 15.625 μg/ml for the
n-hexane fraction, indicating that this fraction was active
against the standard strain (MIC = 15.625 μg/ml). By
contrast, all wells were pink for the aqueous fraction,
suggesting that this fraction was not active against the
bacteria within the exposure concentrations used for the
experiment. The ethyl acetate fraction was active against
M. tuberculosis H37Rv (MIC = 0.195 μg/ml), indicating
that this fraction is the most active fraction of P. stella-
tum chloroform extract (Table 5). As described above,
all wells treated with the vehicle were pink, demonstrat-
ing no inhibitory role of the vehicle.
Discussion
Current TB therapy consists of treatment with a
combination of drugs. This combination therapy causes
hepatotoxicity as the major side effect as well as develop-
ment of drug resistance. To avert toxicity and reduce
ineffectiveness of current anti-TB drugs, medicinal plants
are considered as potential anti-tuberculosis agents that
can be used in combination with the standard anti-
Table 1 Outcome of extraction in the preparation of crude extracts
Plants Part (s)
used
Solvent Extraction method Raw material (g) Yield g (%) Physical appearance
Otostegia integrifolia roots chloroform maceration 300 2 (0.67) whitish powder
roots 80% methanol soxhlet 200 1 (0.5) deep red gumy
Pterolobium stellatum roots chloroform maceration 500 10 (2) brownish resin
roots 80% methanol soxhlet 200 1.5 (0.75) deep red gumy
Persea americana Leaves 80% methanol soxhlet 500 20 (4) Oily black
Acetone maceration 300 3 (1) gumy black
Carissa edulis roots chloroform maceration 300 2 (0.67) light green
Vernonia amygdalina roots chloroform maceration 300 1.5 (0.5) black powder
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tuberculosis drugs or alone [20]. In this study, antimyco-
bacterial activity of crude extract of O. integrifolia, V.
amygdalina, C. edulis, P. americana, P. stellatum and as
well as fractions of the most active crude extract was
investigated.
From the aerial parts of O. integrifolia otostegin A,
otostegin B, 15-epi-otostegin B, preleoheterin, leoheterin,
and related compounds, including leopersin C, 15-epi-leo-
persin C, ballonigrin, vulgarol, and 8-O-acetylharpagide
were isolated and reported. In addition, the essential oil
and chloroform extract of air-dried leaves of O. integrifolia
constitute monoterpenes, sesquiterpenes, diterpenes and
their derivatives were identified [21]. Phytochemical
screening study report indicated that saponins, glycosides
and tannins, which are known to be bioactive purgative
principles were present in V. amygdalina extract.
Flavonoids are also present in the plant that possess anti-
oxidant activity and may play a beneficial role in cancer
prevention and offer some protection against diabetes and
atherosclerosis [22].
The chemical compositions of C. edulis have extensively
been reported. Roots contain an active ingredient, carissin
that may prove useful in the treatment of cancer. The
twigs contain quebrachytol and cardioglycosides that are
useful as an anthelmintic against tapeworm [23] and the
roots contain lupeol (has antiviral activity), oleuropein,
carissol and β-amyrin [24]. Major chemical constituents of
P. americana include the following: the leaf contains
volatile oil, flavonoids and coumarins; the fruit contains
sesquiterpenes and carbohydrates; the seed contains fixed
oil consisting of vitamins A, D3, alpha tocopherol and
cholesterol. The fruit is a significant source of protein,
monounsaturated fatty acids, vitamin A, thiamin, ribofla-
vin, niacin, vitamin B6, vitamin C, vitamin E, folate,
vitamin K, pantothenic acid, magnesium, manganese,
phosphorus and the amino acids tryptophan, valine,
Table 3 Antimycobacterial activity test of Pterolobium stellatum
chloroform extract against MDR-TB clinical isolates









2.500 blue blue blue
1.250 blue blue blue
0.625 blue blue blue
0.312 blue blue blue
0.156 blue blue blue
0.078 pink blue pink
0.039 pink pink pink
0.019 pink pink pink
0.009 pink pink pink
0.005 pink pink pink
0.0024 pink pink pink
DMSO control 2.5–0.0024% Pink Pink Pink
Isoniazid 1 ×10−3 Pink Pink Pink
0.5 ×10−3 Pink Pink Pink
0.25 ×10−3 Pink Pink Pink
0.125 ×10−3 Pink Pink Pink
0.06 ×10−3 Pink Pink Pink
0.03 ×10−3 Pink Pink Pink
Growth control - Pink Pink Pink
Sterility control - blue blue blue
Experiments were carried out in triplicate and results are expressed as means
of three replicate experiments. - = Not applicable
Table 4 Test suspension colors obtained from fractions tested against Mycobacterium tuberculosis H37Rv
n-hexane Ethyl Acetate Aqueous Isoniazid DMSO
Conc (μg/ml) Color Conc (μg/ml) Color Conc (μg/ml) Color Conc (μg/ml) Color Conc (%) Color
1000 blue 200 blue 1000 pink 1 blue 2.5 pink
500 blue 100 blue 500 pink 0.5 blue 1.25 pink
250 blue 50 blue 250 pink 0.25 blue 0.625 pink
125 blue 25 blue 125 pink 0.125 blue 0.312 pink
62.5 blue 12.5 blue 62.5 pink 0.06 pink 0.156 pink
31.25 blue 6.25 blue 31.25 pink 0.03 pink 0.078 pink
15.625 blue 3.125 blue 15.625 pink – – 0.039 pink
7.813 pink 1.563 blue 7.813 pink – – 0.02 pink
3.906 pink 0.781 blue 3.906 pink – – 0.01 pink
1.953 pink 0.391 blue 1.953 pink – – 0.005 pink
0.977 pink 0.195 blue 0.977 pink – – 0.0024 pink
Experiments were carried out in triplicate and results are expressed as means of three replicate experiments. - = Not applicable
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tyrosine, threonine, phenylalanine and methionine [25].
Chemical classes present in P. stellatum 80% root extract
are terpenoids, saponins and tannins and had antibacterial
activity as reported by previous study.
The result of the study revealed that three of the experi-
mental plants had significant anti-tuberculosis activity. The
activity was seen with chloroform and methanol extracts of
P. stellatum and O. integrifolia as well as with methanol
and acetone extracts of P. americana. In addition, fractions
from the most active plant, P. stellatum had demonstrated
promising antimycobacterial activity [8].
MICs of all experimental plant extracts and solvent
fractions of the most active plant extract were deter-
mined by CFU method and microplate resazurin assay
method. As evidenced from Tables 2 and 3, P. stellatum
chloroform extract was endowed with lower MIC by
CFU method than by microplate resazurin assay method,
although test organisms were different. It has been
reported that the MIC exhibited by a compound/extract
depends on the technique used for determination. MICs
obtained in a liquid medium are lower than that
obtained from a solid medium, as the drug has to diffuse
through the matrix in the solid medium in order to exert
activity [20].
MIC of P. stellatum chloroform extract was evaluated
using CFU and Resazurin indicator method. The finding
in the later method revealed that the MICs were 0.078,
0.156 and 0.156 mg/ml against AOZ8W-4, AOA8W-4
and SO38SW-4 MDR-TB clinical isolates, respectively.
However, the extract had lower MIC (0.039 mg/ml)
against the standard strain. The difference in MICs
might be ascribed to the difference in susceptibility of
the standard strain and MDR-TB clinical isolates to-
wards the extract. Furthermore, this apparent difference
might be attributed to more favorable growth conditions
provided by agar culture medium to extract-treated
bacilli in colony count method or the drug susceptible
standard strain and the drug resistant strain might have
different growth conditions. Another cause for the
different MICs of P. stellatum chloroform extract could
be the slight difference in sensitivities of colony count
method and resazurin indicator method as reported by
Taneja and Tyagi [26]. According to this study, Resazurin
indicator assay was noted to be superior to the colony
count assay in that it distinguished between metabolically
active dormant bacteria and non-viable organisms, unlike
the colony count assay that could not differentiate be-
tween these two populations.
In this study, P. stellatum chloroform extract showed
promising activity against M. tuberculosis H37Rv and
AOZ8W-4, with complete inhibition at 0.039 mg/ml and
0.078 mg/ml, respectively. These values are within the
range stated by the Clinical and Laboratory Standards
Institute [27]. In addition, the MDR-TB clinical isolates
were resistant to isoniazid, while this plant was active
against the clinical isolates of MDR-TB, possibly suggest-
ing that the plant could have an obvious advantage over
the standard drug. Moreover, the activity displayed by
this extract makes the plant to be a promising plant
according to Tosun et al. [28], which states that com-
pounds with an MIC of less than 10 μg/ml, and ideally
less than 2 μg/ml could have a potential for further
investigation.
There is sparse data in the literature about the antimy-
cobacterial activity of P. stellatum, making comparison a
bit difficult. A study reported that 80% ethanol leaf
extract of the plant had shown activity (MIC = 250 mg/ml)
on M. tuberculosis H37Rv [9]. This value is much higher
than the value obtained in this study, possibly indicating
that non-polar constituents might be more responsible for
the observed antitubercular activity. Efforts made to com-
pare activity of the chloroform extract of P. stellatum with
other plants showed either better or comparable activity.
Activity was better compared to stem bark extract of
Anogeissus leiocarpus [13] and comparable to that of the
chloroform leaf extract of Byrsonima fagifolia [29].
Although 80% methanol extract of P. stellatum (MIC =
0.312 mg/ml), P. americana (MIC = 2.5 mg/ml) and O.
integrifolia (MIC = 0.312 mg/ml) as well as chloroform
extract of O. integrifolia (MIC = 0.312 mg/ml) and acetone
extract of P. americana (MIC = 1.25 mg/ml) had
significantly higher activity than vehicle-treated controls,
they failed to exhibit promising activity according to
Tosun [30] or Sánchez [31]. The MICs in this finding are
lower/equal than a study done on methanol extract of
Pelargonium sidoides (MIC = 5000 μg/ml) as well as
methanol extract of Capparis brassi, Entada africana
and Combretum species (MIC = 1250 μg/ml each)
against M. tuberculosis H37Rv [12]. However, the
MICs were higher than that of chloroform extract of
Byrsonima fagifolia (MIC = 62.5 μg/ml) [29]. This dif-
ference might be imputed to the fact that different
plant species may contain different active constituents
at varying amount and/or different in vitro methods
were used.
Table 5 Minimum inhibitory concentrations of solvent fractions
against Mycobacterium tuberculosis H37Rv
Solvent fraction Minimum Inhibitory Concentration
(μg/ml)
n-hexane fraction 15.625
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Previous studies reported several plants with promising
anti-tubercular activity [13, 29–33]. Studies had mostly
reported activity in the plant families of Asteraceae,
Lamiaceae, Fabaceae and Apiaceae, among others [34]. It
is noticeable from the present study that plants exhibiting
activity belong to Fabaceae, Lamiaceae and Lauraceae
families, which is in agreement with the plant families
previously reported [34].
Antimycobacterial activity evaluation revealed that P.
stellatum chloroform root extract to have a better
activity and further fractionation was pursued and activ-
ity of the fractions was evaluated. Accordingly, the ethyl
acetate fraction was found to be the most active fraction,
based on MIC values (0.195 μg/ml), which indicated that
antimycobacterial constituents were contained in this
fraction. Further work is underway to isolate and
characterize active principles from this fraction.
Conclusion
The results of this study showed that P. stellatum, O.
integrifolia and P. americana are endowed with a sig-
nificant antimycobacterial activity. However, it seems
that the potential to develop new compounds against
both drug susceptible as well as MDR-TB rests with
P. stellatum. The ethyl acetate fraction of this plant
was the most active solvent fraction and further study
is underway with this fraction. Although the present
study provided evidence for the traditional use of
some of the plants for treatment of TB, the evidence
did not support the use of V. amygdalina and C. edulis for
the same.
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